1. Home
  2. ATNM vs RECT Comparison

ATNM vs RECT Comparison

Compare ATNM & RECT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

N/A

Current Price

$1.13

Market Cap

36.8M

Sector

Health Care

ML Signal

N/A

Logo Rectitude Holdings Ltd

RECT

Rectitude Holdings Ltd

N/A

Current Price

$1.37

Market Cap

20.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ATNM
RECT
Founded
2000
1997
Country
United States
Singapore
Employees
N/A
111
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.8M
20.9M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ATNM
RECT
Price
$1.13
$1.37
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
103.3K
1.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
30.60
N/A
EPS
N/A
N/A
Revenue
$81,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$12.74
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$1.30
52 Week High
$1.95
$4.98

Technical Indicators

Market Signals
Indicator
ATNM
RECT
Relative Strength Index (RSI) 45.01 33.03
Support Level $1.02 $1.32
Resistance Level $1.25 $1.94
Average True Range (ATR) 0.07 0.08
MACD 0.01 -0.00
Stochastic Oscillator 46.51 13.09

Price Performance

Historical Comparison
ATNM
RECT

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About RECT Rectitude Holdings Ltd

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.

Share on Social Networks: